logo

For the Inventor, By the Inventor

Wokingham, United Kingdom

Jonathan Mark Bentley

This inventor holds 13 USPTO granted patents and 1 EPO patent, primarily in Anti-Obesity Compounds. Top assignees: Vernalis Research Limited, Hoffmann-La Roche Inc., Other. Active years: 2002-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Mark Bentley. Retrieved from https://idiyas.com/inventor/jonathan-mark-bentley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13


Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Winnersh, Wokingham RG41 5UA, GB (2002)
  • Winnersh, GB (2002)
  • Reading, GB (2003 - 2007)
  • Wokingham, GB (2002 - 2008)

Company Filing History:

goldMedal10 out of 43 
 
Vernalis Research Limited
 patents
silverMedal5 out of 5,035 
 
Hoffmann-La Roche Inc.
 patents
bronzeMedal3 out of 834,708 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2008

Loading Chart...
Loading Chart...
Areas of Expertise:
5HT2C Receptor Agonists
Morpholine Derivatives
Piperazine Derivatives
Indole Derivatives
Hexahydropyrazino Indoles
Fused Indole Derivatives
Aza-Indolyl Derivatives
Indazole Derivatives
Pyrroloindoles
5-HT2 Receptor Activity
Pharmaceutical Compositions
Medicinal Applications
13 patents (USPTO):Explore Patents
1. 7323466 - Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity (2008-01-29),
2. 7253281 - Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles (2007-08-07),
3. 7098337 - 1,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivatives (2006-08-29),
4. 7022707 - Piperazine derivatives (2006-04-04),
5. 6933387 - Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles (2005-08-23),
6. 6706750 - Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal application (2004-03-16),
7. 6610685 - Fused indole derivatives (2003-08-26),
8. 6583134 - Aza- indolyl derivatives for treating obesity (2003-06-24),
9. 6552062 - Indazole derivatives with 5-HT2 receptor activity (2003-04-22),
10. 6479534 - Indoline derivatives and method of treating obesity (2002-11-12),
11. 6433175 - Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists (2002-08-13),
12. 6380238 - Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands (2002-04-30),
13. 6365598 - Pyrroloquinolines for treatment of obesity (2002-04-02),

Title: The Innovations of Jonathan Mark Bentley

Introduction

Jonathan Mark Bentley is a notable inventor based in Wokingham, GB. He holds an impressive portfolio of 13 patents, showcasing his contributions to the field of medicinal chemistry. His work primarily focuses on developing innovative compounds for the treatment of various health conditions.

Latest Patents

Among his latest patents, Bentley has developed morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity. This invention refers to chemical compounds of a specific formula, which can be utilized in the preparation of medicaments. Another significant patent involves anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles. This invention is directed towards derivatives that can be used in pharmaceutical preparations for treating or preventing disorders of the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity, and sleep apnea.

Career Highlights

Throughout his career, Bentley has worked with prominent companies such as Vernalis Research Limited and Hoffmann-La Roche Inc. His experience in these organizations has significantly contributed to his expertise in pharmaceutical research and development.

Collaborations

Bentley has collaborated with notable colleagues, including Jonathan Richard Anthony Roffey and David Reginald Adams. These partnerships have likely enhanced his innovative capabilities and broadened his research horizons.

Conclusion

Jonathan Mark Bentley's contributions to medicinal chemistry through his patents and collaborations highlight his significant role as an inventor. His work continues to impact the development of treatments for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…